Financhill
Sell
13

LSB Quote, Financials, Valuation and Earnings

Last price:
$1.05
Seasonality move :
-21.06%
Day range:
$1.02 - $1.15
52-week range:
$0.87 - $8.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
0.23x
Volume:
143.9K
Avg. volume:
570.5K
1-year change:
-79.2%
Market cap:
$19.8M
Revenue:
$80.2M
EPS (TTM):
-$2.01

Earnings Data

Next earnings date for LSB
Jul 21
2025
Most recent earnings per share
-$1.57
Missed by $1.48
(Sep 30/2023)
Consensus Estimate
-$0.08
(Sep 30/2023)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LSB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -$0.06 --
12/19/2024 Q3 -- -- -- -$0.08 --
08/15/2024 Q2 -- -- -- -$0.09 --
04/19/2024 Q1 $21.8M -- -- -$0.08 --
12/31/2023 Q4 $19.8M -- -- -$0.06 --
09/30/2023 Q3 $20.2M $13.4M -$1.57 -$0.08 -$1.48
06/30/2023 Q2 -- $25.2M -$1.07 -- --
09/30/2022 Q3 -- $28.3M -$0.46 -- --
06/30/2022 Q2 -- $31.1M -$0.89 -- --

LakeShore Biopharma Earnings Questions

  • How Much did LakeShore Biopharma Generate in Revenue Last Quarter?

    LakeShore Biopharma reported $13.4M worth of top line sales in its most recent quarter.

  • Did LakeShore Biopharma Beat Earnings Last Quarter?

    LakeShore Biopharma announced earnings per share of -$1.57 which represents a miss of analyst forecast a -$0.08 per share.

  • Is LakeShore Biopharma Profitable?

    LakeShore Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for LakeShore Biopharma EPS Next Year?

    LakeShore Biopharma's earnings are forecast to decrease from -$5.66 per share to -$0.45 per share next year representing a decrease of -56.61%.

  • When is LakeShore Biopharma's Earnings Date?

    LakeShore Biopharma's next earnings date is July 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock